The company expired its plan on June 21, 2023.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+26.62% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.79% | 231B | |
+5.37% | 200B | |
-8.88% | 195B | |
-6.26% | 145B |